Compare GSK plc (GSK) vs Valero Energy Corporation (VLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Valero Energy Corporation — how do they compare? GSK plc trades at $52.4 (market cap $101.34B), while Valero Energy Corporation trades at $302 (market cap $86.90B). The key difference: GSK plc is the larger of the two by market cap, and GSK plc pays the higher dividend (3.49%). Which is the better fit depends on your goals.
| GSK | VLO | |
|---|---|---|
Market Cap | $101.34B | $86.90B |
Sector | Health | Energy |
52-Week High | $61.18 | $301.43 |
52-Week Low | $36.20 | $131.77 |
Enterprise Value | $121.95B | $92.66B |
Dividend Yield | 3.49% | 1.64% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK's stock trades at $51.25, down 1.99% on the day, with a bearish technical signal from moving averages. Fundamentally, the company shows strong profitability with a 17.78% net margin and 36.42% ROE, supported by a consistent earnings beat history. Recent positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline progress. Valuation appears reasonable with a P/E of 13.71 and EV/EBITDA of 9.16.
The outlook balances a solid core business and promising oncology pipeline against a mixed analyst consensus and near-term cash flow pressures. Key opportunities lie in execution of new drug launches and the upcoming CEO strategy update, while risks include clinical trial setbacks, competitive pressures, and integration of potential acquisitions like Nuvalent.
Valero Energy (VLO) trades at $301.43, up 1.91% with strong technical momentum and bullish moving averages. Recent earnings consistently beat estimates, with Q1 2026 EPS of $4.22 versus $3.16 expected. Revenue declined to $122.69B in 2025 but net income margin improved to 3.37%. The stock benefits from elevated refining margins and positive analyst sentiment, with 55.55% recommending Buy.
Outlook remains positive due to robust refining margins and strategic positioning, though risks include volatile energy markets and declining revenue trends. The consensus price target is $276.22, below current levels, suggesting potential near-term consolidation. Investors should weigh strong profitability against cyclical industry headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Valero Energy Corporation
Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Read more on VLO →
